tiprankstipranks
Trending News
More News >
Brainsway (IL:BWAY)
:BWAY
Israel Market
Advertisement

Brainsway (BWAY) Earnings Dates, Call Summary & Reports

Compare
0 Followers

Earnings Data

Report Date
Mar 11, 2026
TBA (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
15.2
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 11, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and system shipments, successful strategic investments, and improved financial guidance. However, there were increased operating expenses and delays in FDA clearance for a strategic partner's product. Overall, the positives significantly outweigh the negatives.
Company Guidance
In the recent BrainsWay Third Quarter 2025 Earnings Conference Call, the company reported a record quarterly revenue of $13.5 million, marking a 29% increase from the previous year, driven by the shipment of 90 Deep TMS systems, a 43% rise year-over-year, expanding their installed base to over 1,600 systems globally. With increased visibility for the remainder of the year, BrainsWay raised its full-year revenue guidance to $51 million to $52 million from the previous range of $50 million to $52 million, and projected operating profit margins of 6% to 7%, up from 4% to 5%, and adjusted EBITDA margins of 13% to 14%, up from 12% to 13%. The company emphasized strategic efforts including minority interest investments in mental health providers, with utilization up over 50% in certain clinics, and highlighted regulatory advancements like the U.S. FDA's approval for an accelerated Deep TMS protocol for treating major depressive disorder, anticipated to enhance market appeal. BrainsWay's performance reflects strong market demand with a book-to-bill ratio of 1.3x and remaining performance obligations of $65 million, signaling solid future revenue prospects.
Record Quarterly Revenue
BrainsWay reported record quarterly revenue of $13.5 million for Q3 2025, a 29% increase compared to the same period last year.
Increase in Deep TMS System Shipments
The company shipped 90 Deep TMS systems during the quarter, a 43% increase compared to the same period last year, bringing the total installed base to over 1,600 systems globally.
Raised Financial Guidance
BrainsWay raised the midpoint of their full-year 2025 revenue guidance to $51-52 million, up from $50-52 million, and increased expected operating profit to 6-7% of revenue from 4-5%.
FDA Approval for Accelerated Protocol
The U.S. FDA granted an expansion of the treatment protocol for the Deep TMS system to include an accelerated protocol for major depressive disorder, potentially improving patient convenience and appeal.
Strategic Investments and Growth
BrainsWay made strategic minority investments in mental health providers, with utilization of Deep TMS systems at partner clinics increasing over 50% since collaboration.
Strong Financial Performance
Q3 2025 gross profit was $10.2 million, with a strong gross margin of 75%. Net profit increased to $1.6 million from $0.7 million in Q3 2024.

Brainsway (IL:BWAY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IL:BWAY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 11, 2026
2025 (Q4)
- / -
15.2
Nov 11, 2025
2025 (Q3)
- / 13.80
7.486.49% (+6.40)
Aug 13, 2025
2025 (Q2)
- / 19.20
6.7186.57% (+12.50)
May 13, 2025
2025 (Q1)
- / 10.60
1.2783.33% (+9.40)
Mar 11, 2025
2024 (Q4)
- / 15.20
1.5913.33% (+13.70)
Nov 12, 2024
2024 (Q3)
- / 7.40
-2.6384.62% (+10.00)
Aug 06, 2024
2024 (Q2)
- / 6.70
-18.3136.61% (+25.00)
May 08, 2024
2024 (Q1)
- / 1.20
-25.9104.63% (+27.10)
Mar 06, 2024
2023 (Q4)
- / 1.50
-40.8103.68% (+42.30)
Nov 15, 2023
2023 (Q3)
- / -2.60
-51.994.99% (+49.30)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IL:BWAY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 11, 2025
2625.002540.00-3.24%
Aug 13, 2025
2086.002220.00+6.42%
May 13, 2025
1553.001690.00+8.82%
Mar 11, 2025
1710.001772.00+3.63%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Brainsway (IL:BWAY) report earnings?
Brainsway (IL:BWAY) is schdueled to report earning on Mar 11, 2026, TBA (Confirmed).
    What is Brainsway (IL:BWAY) earnings time?
    Brainsway (IL:BWAY) earnings time is at Mar 11, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Brainsway stock?
          The P/E ratio of Brainsway is N/A.
            What is IL:BWAY EPS forecast?
            Currently, no data Available
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis